PREVALENCE AND RISK FACTORS OF SARCOPENIA IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS
Keywords:
HIV infection, prevalence, risk factors, sarcopeniaAbstract
Background : HIV patients have a life expectancy that is close to the life expectancy of the general population after using ARVs, so that increasing HIV patients suffer from age-related diseases and chronic inflammation, one of which is sarcopenia. Research on sarcopenia in HIV patients in Indonesia is still limited, so the author is interested in conducting this study with the aim of determining the prevalence and risk factors for sarcopenia in HIV patients.
Method : A cross-sectional study conducted at Sanjiwani Hospital Gianyar on October 2025. This study included 125 HIV patients, aged 20-75 and receiving ARV for more than a year. Sarcopenia was determined based on the 2019 Asian Working Group for Sarcopenia (AWGS) criteria, health status based on questionnaires, measurments, and medical records. Logistic regression analysis was used to determine the risk of sarcopenia occurrence.
Result : A total of 125 sampel consisted of 40.8% women, and 59.2% men with an average age of 48.35 ± 10.8 years. Most of them had suffered from HIV for more than 5 years (60%). The prevalence of sarcopenia was 20.8%. Risk factors for sarcopenia included advanced age (≥50 years, OR =6,01, female gender (OR=5,07).
Conclusion : This prevalence of sarcopenia in HIV patients was 20.8%, advance age, female gender are risk factors for sarcopenia in HIV patients.
References
Wasserman P, Segal-Maurer S, Rubin DS. High prevalence of low skeletal muscle mass associated with male gender in midlife and older HIV-infected persons despite CD4 cell reconstitution and viral suppression. J Int Assoc Provid AIDS Care 2014; 13(2): 145-52. http://dx.doi.org/10.1177/2325957413495919 PMID: 24067494
Luciana Cardoso Martins1, Marcelo Palmares Oliveira e Silva1, Ana Célia Oliveira dos Santos, Vera Magalhães da Silveira and Paulo Sérgio Ramos de Araújo, Martins et al. Prevalence and associated factors related to sarcopenia in people living with HIV/AIDS BMC Infectious Diseases 2024; 24:933-942
Chen LK, Woo J, Assantachai P, Auyeung TW, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. JAMDA 2020: 1-8
Agus A, Agus S, Suka A. Interleukin-15 is a significant predictor of sarcopenia in human immunodeficiency virus infected patients on antiretroviral therapy: A cross-sectional study. Asian Pac J Trop Med 2022; 15(8):361-366.
Seyed Alinagh S, Ghayomzadeh M, Mirzapour P, Maroufi SF , Pashaei Z, et al. A systematic review of sarcopenia prevalence and associated factors in people living with human immunodeficiency virus. Journal of Cachexia, Sarcopenia and Muscle 2023; 14: 1168–1182
Yuenyongchaiwat K, Chamnansingh C, Akekawatchai C. Investigating the Contributing Risk Factors toward Sarcopenia Prevalence and its Development in Human Immunodeficiency Virus (HIV) Patients. Open Public Health J 2024; 7: e18749445288299.
Abdul Aziz SA, Mcstea M, Ahmad Bashah NS, Chong ML, Ponnampalavanar S, Syed Omar SF, et al. Assessment of sarcopenia in virally suppressed HIV-infected Asians receiving treatment. AIDS 2018; 32(8): 1025-34.http://dx.doi.org/10.1097/QAD.0000000000001798
Larsson, Lars, et al. “Sarcopenia: Aging-Related Loss of Muscle Mass and Function.” Physiological Reviews, vol. 99, no. 1, 2019, pp. 427–511, https://doi.org/10.1152/physrev.00061.2017
Soh Y, Won CW. Sex differences in impact of sarcopenia on falls in community-dwelling Korean older adults. BMC Geriatr. 2021 Dec 18;21(1):716. doi: 10.1186/s12877-021-02688-8. PMID: 34922482; PMCID: PMC8684116.
Bonato M, Turrini F, Galli L, Banfi G, Cinque P. The role of physical activity for the management of sarcopenia in people living with HIV. Int J Environ Res Public Health 2020; 17(4): 1283. http://dx.doi.org/10.3390/ijerph17041283 PMID: 32079244
Guimarães NS, Raposo MA, Greco D, Tupinambás U, Premaor MO. People Living With HIV, Lean Mass, and Sarcopenia: A Systematic Review and Meta-Analysis. Journal of Clinical Densitometry. 2022 Jan 1;25(1):113–23.
Deminice R, Oliveira VHF, Webel AR, Erlandson KM. Sarcopenia related to human immunodeficiency virus: Protective effects of exercise. Exerc Sport Sci Rev 2022; 50(2): 73-80. http://dx.doi.org/10.1249/JES.0000000000000282 PMID:35029356
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Putu Ayu Kevin Komala Dewi Mahayuna Putri, I Wayan Yuna Ariawan, I Wayan Eka Saputra (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
